Arbital Health, a healthcare technology company that provides critical infrastructure for providers and payers to successfully manage risk-based contracts, today announced a $31M Series B funding round led by Valtruis, with participation from existing investors Transformation Capital, Shaper Capital, and Healthy Ventures. The investment will expand Arbital Health’s payer and provider facing capabilities and accelerate value-based care contract performance monitoring, management and reconciliation across all major risk models. In addition, the new funds will be used to grow Arbital Health’s market-leading actuarial team, enhance the company’s benchmarking capabilities, and expand the company’s AI-powered platform that helps providers and payers deliver on their promise of better patient outcomes and sustainable financial performance.
As healthcare providers and payers expand into more outcomes-based payment models, Arbital Health has developed a platform to reduce complexity and administrative burden while ensuring that all market participants can better monitor and improve their performance. Arbital Health’s platform is powered by its best-in-class actuarial team, which includes some of the most experienced value-based care experts in the country.
Read More – Reach Security Receives $10M Strategic Investment from M12
“Arbital Health has built something the healthcare industry desperately needs: the critical infrastructure that empowers payers and providers to reconcile their risk-based contracts with accelerated performance insights,” said Mike Spadafore, Managing Director at Valtruis. “With healthcare’s top actuaries and an advanced AI-powered platform, Arbital Health is addressing the financial and performance issues that have long held back value-based care’s success. We’re proud to support their team as they continue to drive growth, value, and better outcomes in healthcare.”
Since its founding in 2024, Arbital Health has built its client roster to include more than 40 payers, providers, digital point solutions, value-based care enablers, and integrated delivery networks. In addition, Arbital has launched and onboarded more than 600,000 patient lives to its platform and assembled the most experienced value-based care actuary team to meet the growing demand to better manage complex risk-based contracts.
Read More – ARTBIO Raises $132M in Series B Financing
